The Role of Cytochrome P450 Enzymes in Carcinogen Activation and Detoxication: an in Vivo-in Vitro Paradox

Overview

Journal Carcinogenesis

Specialty Oncology

Date 2018 May 5

PMID 29726902

Citations 25

Authors

Lindsay Reed

Volker M Arlt

David H Phillips

Affiliations

Soon will be listed here.

Abstract

Many chemical carcinogens require metabolic activation via xenobiotic-metabolizing enzymes in order to exert their genotoxic effects. Evidence from numerous in-vitro studies, utilizing reconstituted systems, microsomal fractions and cultured cells, implicates cytochrome P450 enzymes as being the predominant enzymes responsible for the metabolic activation of many procarcinogens. With the development of targeted gene disruption methodologies, knockout mouse models have been generated that allow investigation of the in-vivo roles of P450 enzymes in the metabolic activation of carcinogens. This review covers studies in which five procarcinogens representing different chemical classes, benzo[a]pyrene, 4-aminobiphenyl (4-ABP), 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-9H-pyrido[2,3-b]indole and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, have been administered to different P450 knockout mouse models. Paradoxically, while in-vitro studies using subcellular fractions enriched with P450 enzymes and their cofactors have been widely used to determine the pathways of activation of carcinogens, there is evidence from the in-vivo studies of cases where these same enzyme systems appear to have a more predominant role in carcinogen detoxication rather than activation.

Citing Articles

Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders.

Pagoni M, Zogopoulos V, Kontogiannis S, Tsolakou A, Zoumpourlis V, Tsangaris G Cancer Genomics Proteomics. 2025; 22(2):285-305.

PMID: 39993800 PMC: 11880924. DOI: 10.21873/cgp.20502.

Benzo(a)pyrene and Gut Microbiome Crosstalk: Health Risk Implications.

Mauliasari I, Lee H, Koo S, Hitayezu E, Kieu A, Lee S Toxics. 2025; 12(12).

PMID: 39771153 PMC: 11840287. DOI: 10.3390/toxics12120938.

The Influence of Genetic Polymorphisms in Cytochrome P450 (CYP1A1 and 2D6) Gene on the Susceptibility to Philadelphia Negative Chronic Myeloid Leukemia in Sudanese Patients.

Elderdery A, Idris H, Alruwaili S, Tebien E, Alsrhani A, Alenazy F Int J Mol Sci. 2025; 25(24.

PMID: 39769254 PMC: 11728260. DOI: 10.3390/ijms252413493.

Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review.

Mokhosoev I, Astakhov D, Terentiev A, Moldogazieva N Cells. 2024; 13(23).

PMID: 39682707 PMC: 11639897. DOI: 10.3390/cells13231958.

Phenanthrene-Induced Cytochrome P450 Genes and Phenanthrene Tolerance Associated with Gene.

Cabello-Hurtado F, El Amrani A Plants (Basel). 2024; 13(12).

PMID: 38931123 PMC: 11207427. DOI: 10.3390/plants13121692.

References

Turesky R, Lang N, Butler M, Teitel C, Kadlubar F . Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis. 1991; 12(10):1839-45. DOI: 10.1093/carcin/12.10.1839. View

Shimada T, Hayes C, Yamazaki H, Amin S, Hecht S, Guengerich F . Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 1996; 56(13):2979-84. View

Sagredo C, Mollerup S, Cole K, Phillips D, Uppstad H, Ovrebo S . Biotransformation of benzo[a]pyrene in Ahr knockout mice is dependent on time and route of exposure. Chem Res Toxicol. 2009; 22(3):584-91. DOI: 10.1021/tx8003664. View

Reed L, Mrizova I, Barta F, Indra R, Moserova M, Kopka K . Cytochrome b impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b /P450 reductase null (HBRN) mice. Arch Toxicol. 2018; 92(4):1625-1638. PMC: 5882632. DOI: 10.1007/s00204-018-2162-7. View

Wilkening S, Stahl F, Bader A . Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos. 2003; 31(8):1035-42. DOI: 10.1124/dmd.31.8.1035. View

Uno S, Dalton T, Derkenne S, Curran C, Miller M, Shertzer H . Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol Pharmacol. 2004; 65(5):1225-37. DOI: 10.1124/mol.65.5.1225. View

. Chemical agents and related occupations. IARC Monogr Eval Carcinog Risks Hum. 2012; 100(Pt F):9-562. PMC: 4781612. View

Gu J, Weng Y, Zhang Q, Cui H, Behr M, Wu L . Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem. 2003; 278(28):25895-901. DOI: 10.1074/jbc.M303125200. View

Kondraganti S, Fernandez-Salguero P, Gonzalez F, Ramos K, Jiang W, Moorthy B . Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo. Int J Cancer. 2002; 103(1):5-11. DOI: 10.1002/ijc.10784. View

10.

Sagredo C, Ovrebo S, Haugen A, Fujii-Kuriyama Y, Baera R, Botnen I . Quantitative analysis of benzo[a]pyrene biotransformation and adduct formation in Ahr knockout mice. Toxicol Lett. 2006; 167(3):173-82. DOI: 10.1016/j.toxlet.2006.09.005. View

11.

Nebert D, Dalton T . The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer. 2006; 6(12):947-60. DOI: 10.1038/nrc2015. View

12.

Kucab J, van Steeg H, Luijten M, Schmeiser H, White P, Phillips D . TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts. Mutat Res. 2015; 773:48-62. PMC: 4547099. DOI: 10.1016/j.mrfmmm.2015.01.013. View

13.

Hamouchene H, Arlt V, Giddings I, Phillips D . Influence of cell cycle on responses of MCF-7 cells to benzo[a]pyrene. BMC Genomics. 2011; 12:333. PMC: 3145607. DOI: 10.1186/1471-2164-12-333. View

14.

Zhou X, DAgostino J, Xie F, Ding X . Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. J Pharmacol Exp Ther. 2012; 341(1):233-41. PMC: 3310698. DOI: 10.1124/jpet.111.190173. View

15.

Henderson C, McLaughlin L, Wolf C . Evidence that cytochrome b5 and cytochrome b5 reductase can act as sole electron donors to the hepatic cytochrome P450 system. Mol Pharmacol. 2013; 83(6):1209-17. DOI: 10.1124/mol.112.084616. View

16.

Ohgaki H, Matsukura N, Morino K, Kawachi T, Sugimura T, Takayama S . Carcinogenicity in mice of mutagenic compounds from glutamic acid and soybean globulin pyrolysates. Carcinogenesis. 1984; 5(6):815-9. DOI: 10.1093/carcin/5.6.815. View

17.

Pelkonen O, Nebert D . Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev. 1982; 34(2):189-222. View

18.

Garattini E, Coccia P, Romano M, Jiritano L, Noseda A, Salmona M . Prostaglandin endoperoxide synthetase and the activation of benzo(a)pyrene to reactive metabolites in vivo in guinea pigs. Cancer Res. 1984; 44(11):5150-5. View

19.

Snyderwine E, Yu M, Schut H, Kimura S . Effect of CYP1A2 deficiency on heterocyclic amine DNA adduct levels in mice. Food Chem Toxicol. 2002; 40(10):1529-33. DOI: 10.1016/s0278-6915(02)00110-2. View

20.

Turesky R, Konorev D, Fan X, Tang Y, Yao L, Ding X . Effect of Cytochrome P450 Reductase Deficiency on 2-Amino-9H-pyrido[2,3-b]indole Metabolism and DNA Adduct Formation in Liver and Extrahepatic Tissues of Mice. Chem Res Toxicol. 2015; 28(12):2400-10. PMC: 4703101. DOI: 10.1021/acs.chemrestox.5b00405. View